Document is current
Any future updates will be listed below
-
Authors
Ogiya, Daisuke https://orcid.org/0009-0006-1946-8609
Suzuki, Rikio https://orcid.org/0000-0002-2841-6230
Goto, Shun
Nakagawa, Yosuke https://orcid.org/0000-0001-8504-873X
Nasukawa, Miina
Iwata, Shino
Kawai, Hidetsugu https://orcid.org/0000-0002-6055-8968
Toyosaki, Masako https://orcid.org/0009-0008-6455-3831
Machida, Shinichiro
Onizuka, Makoto https://orcid.org/0000-0003-3864-0823
Ogawa, Yoshiaki
Kawada, Hiroshi
-
Funding
Funding for this research was provided by:
the Japan Society for the Promotion of Science (JSPS) through KAKENHI Grant (20H03664, 19K10045)
- License Information
-
More Information
Article History
Received: 30 August 2025
Accepted: 6 October 2025
First Online: 29 October 2025
Declarations
:
: We are complying with the specific requirements of our institution. We have obtained the consent for publication in print and electronically from the patient.
: DO received a grant from Johnson & Johnson Inc; DO, RS, MT, and SM received lecture fees from Johnson & Johnson Inc.; MO received lecture fees from Johnson & Johnson Inc., Pfizer and Miyarisan Pharmaceutical Co. YO was granted clinical trial funds as the principal investigator. The remaining authors have no financial interests.
